We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
+$4.34B
Cap. Flow
-$146M
Cap. Flow %
-0.28%
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79

Top Buys

Rank Stock Value
1
IS
ironSource Ltd.
IS
+$136M
2
TSLA icon
Tesla
TSLA
+$119M
3
VZ icon
Verizon
VZ
+$109M
4
HD icon
Home Depot
HD
+$101M
5
PFE icon
Pfizer
PFE
+$88M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$247M
2
INTC icon
Intel
INTC
+$216M
3
F icon
Ford
F
+$145M
4
GM icon
General Motors
GM
+$143M
5
MU icon
Micron Technology
MU
+$125M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 14.97%
3 Financials 14.22%
4 Consumer Discretionary 11.15%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIV
2176
Aimco
AIV
$377M
$22K ﹤0.01%
2,827
CHCO icon
2177
City Holding Co
CHCO
$2.03B
$22K ﹤0.01%
270
-7,630
-97% -$612K
VTLE
2178
DELISTED
Vital Energy
VTLE
$22K ﹤0.01%
330
-21,270
-98% -$1.5M
HR icon
2179
Healthcare Realty
HR
$7.46B
$20K ﹤0.01%
590
-1,375
-70% -$45.9K
AMTI
2180
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$20K ﹤0.01%
+1,430
New +$28.2K
PING
2181
DELISTED
Ping Identity Holding Corp.
PING
$19K ﹤0.01%
+810
New +$20.6K
GOTU icon
2182
Gaotu Techedu
GOTU
$374M
$18K ﹤0.01%
9,050
STEP icon
2183
StepStone Group
STEP
$3.65B
$18K ﹤0.01%
+440
New +$19.4K
TSHA icon
2184
Taysha Gene Therapies
TSHA
$1.59B
$16K ﹤0.01%
+1,410
New +$21.3K
QTTB icon
2185
Q32 Bio
QTTB
$452M
$15K ﹤0.01%
+231
New +$22.4K
HRMY icon
2186
Harmony Biosciences
HRMY
$2.08B
$12K ﹤0.01%
+290
New +$11.6K
LEG icon
2187
Leggett & Platt
LEG
$1.5B
$9K ﹤0.01%
220
-21,324
-99% -$926K
PMVP icon
2188
PMV Pharmaceuticals
PMVP
$62.9M
$8K ﹤0.01%
+340
New +$8.21K
PRTS icon
2189
CarParts.com
PRTS
$39.7M
$8K ﹤0.01%
+75
New +$10.3K
RLMD icon
2190
Relmada Therapeutics
RLMD
$546M
$8K ﹤0.01%
+360
New +$8.01K
PNT
2191
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$7K ﹤0.01%
+1,330
New +$9.98K
SGFY
2192
DELISTED
Signify Health, Inc.
SGFY
$7K ﹤0.01%
+480
New +$7.43K
GLUE icon
2193
Monte Rosa Therapeutics
GLUE
$1.91B
$5K ﹤0.01%
+240
New +$5.03K
ONTF
2194
DELISTED
ON24
ONTF
$2K ﹤0.01%
+100
New +$1.78K
AAOI icon
2195
Applied Optoelectronics
AAOI
$7.85B
-37,985
Closed -$273K
ALK icon
2196
Alaska Air
ALK
$5.3B
-14,372
Closed -$842K
ARLO icon
2197
Arlo Technologies
ARLO
$1.51B
-53,300
Closed -$342K
AXTA icon
2198
Axalta
AXTA
$7.22B
-4,050
Closed -$118K
BNED icon
2199
Barnes & Noble Education
BNED
$445M
-424
Closed -$424K
CATO icon
2200
Cato Corp
CATO
$64.1M
-28,428
Closed -$470K

Similar funds

Ensign Peak Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
  • Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
  • Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
  • Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
  • Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
  • Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.